Integration of genotypic data into clinical trial design and reporting in hereditary hemorrhagic telangiectasia could help personalize treatment
Atieh Modarresi,
Claire L. Shovlin
Affiliations
Atieh Modarresi
National Heart and Lung Institute, Imperial College London; London
Claire L. Shovlin
National Heart and Lung Institute, Imperial College London; London, UK; NIHR Imperial Biomedical Research Centre; London, UK; Imperial College Healthcare NHS Trust; London
